Reversible binding of cangrelor to the P2Y12 receptor prevents the binding of clopidogrel and prasugrel active metabolites

被引：0
|
作者：
Buckland, R. J. [1 ]
Judge, H. M. [1 ]
Sugidachi, A. [2 ]
Jakubowski, J. A. [3 ]
Storey, R. F. [1 ]
机构：
[1] Univ Sheffield, Sch Med, Cardiovasc Res Unit, Sheffield, S Yorkshire, England
[2] Daiichi Sankyo Co Ltd, Biol Res Labs 2, Tokyo, Japan
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-030
引用
收藏
页码：942 / 942
页数：1
相关论文
共 50 条
  • [1] Cangrelor inhibits the binding of clopidogrel and prasugrel active metabolites to the P2Y12 receptor
    Buckland, R.
    Judge, H. M.
    Sugidachi, A.
    Jakubowski, J. A.
    Storey, R. F.
    EUROPEAN HEART JOURNAL, 2009, 30 : 193 - 193
  • [2] Cangrelor inhibits the binding of the active metabolites of clopidogrel and prasugrel to P2Y12 receptors in vitro
    Judge, Heather M.
    Buckland, Robert J.
    Jakubowski, Joseph A.
    Storey, Robert F.
    PLATELETS, 2016, 27 (03) : 191 - 195
  • [3] The reversible P2Y12 antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function
    Dovlatova, N. L.
    Jakubowski, J. A.
    Sugidachi, A.
    Heptinstall, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (07) : 1153 - 1159
  • [4] Assessment of Prasugrel Antiplatelet P2Y12 Receptor Therapy in a Clopidogrel Nonresponder
    Ha, Thanh
    Nathan, Sandeep
    Mikrut, Krzysztof
    Miller, Jonathan L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 509 - 510
  • [5] Cangrelor: a novel P2Y12 receptor antagonist
    Norgard, Nicholas B.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (08) : 1219 - 1230
  • [6] Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor-Mediated Signaling in Prasugrel-Treated Patients
    Rollini, Fabiana
    Franchi, Francesco
    Tello-Montoliu, Antonio
    Patel, Ronakkumar
    Darlington, Andrew
    Ferreiro, Jose Luis
    Cho, Jung Rae
    Muniz-Lozano, Ana
    Desai, Bhaloo
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    Angiolillo, Dominick J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (04) : 426 - 434
  • [7] The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
    Bouman, Heleen J.
    van Werkum, Jochem W.
    Rudez, Goran
    Leebeek, Frank W. G.
    Kruit, Adrian
    Hackeng, Christian M.
    ten Berg, Jurrien M.
    de Maat, Moniek P. M.
    Ruven, Henk J. T.
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (02) : 379 - 386
  • [8] P2Y12 receptor polymorphism and clopidogrel response: is there a link?
    Angiolillo, D. J.
    Bernardo, E.
    Ramirez, C.
    Cavallari, U.
    Trabetti, E.
    Pignatti, P. F.
    Fernandez-Ortiz, A.
    Macaya, C.
    EUROPEAN HEART JOURNAL, 2005, 26 : 584 - 584
  • [9] Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
    Wilson, William
    Gurvitch, Ronen
    Ajani, Andrew E.
    CARDIOVASCULAR THERAPEUTICS, 2009, 27 (03) : 194 - 198
  • [10] P2Y12 receptor polymorphism and clopidogrel response: Is there a link?
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Ramirez, C
    Cavallari, U
    Trabetti, E
    Sabate, M
    Jimenez-Quevedo, P
    Moreno, R
    Hernandez-Antolin, R
    Banuelos, C
    Escaned, J
    Alfonso, F
    Costa, MA
    Bass, TA
    Macaya, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 190E - 191E
12345